|
1000 | 634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat | n/a | region | qtl |
1000 | 2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat | n/a | region | qtl |
1000 | 2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat | n/a | region | qtl |
1000 | 619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat | n/a | region | qtl |
1000 | 71115 | Niddm15 | Non-insulin dependent diabetes mellitus QTL 15 | 4.8 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1217606 | 11030812 | Rat | n/a | region | qtl |
1000 | 70204 | Niddm20 | Non-insulin dependent diabetes mellitus QTL 20 | 5.1 | 0.000008 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 1217606 | 16960180 | Rat | n/a | region | qtl |
1000 | 1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat | n/a | region | qtl |
1000 | 2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 3813074 | 18274691 | Rat | n/a | region | qtl |
1000 | 2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) | 14 | 3813074 | 18274691 | Rat | n/a | region | qtl |
1000 | 70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat | n/a | region | qtl |
1000 | 724541 | Niddm53 | Non-insulin dependent diabetes mellitus QTL 53 | | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 3813074 | 9088978 | Rat | n/a | region | qtl |
1000 | 1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat | n/a | region | qtl |
1000 | 1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat | n/a | region | qtl |
1000 | 1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat | n/a | region | qtl |
1000 | 2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat | n/a | region | qtl |
1000 | 731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat | n/a | region | qtl |
1000 | 2302277 | Gluco38 | Glucose level QTL 38 | 5.8 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 28035204 | Rat | n/a | region | qtl |
1000 | 631839 | Niddm37 | Non-insulin dependent diabetes mellitus QTL 37 | 3.37 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 95876975 | Rat | n/a | region | qtl |
1000 | 631212 | Bw5 | Body weight QTL5 | 5.43 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 14 | 11030812 | 30320092 | Rat | n/a | region | qtl |
1000 | 1300140 | Srn3 | Serum renin concentration QTL 3 | 3.19 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 14875168 | 30883947 | Rat | n/a | region | qtl |
1000 | 631528 | Scl11 | Serum cholesterol level QTL 11 | 4.9 | | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 14 | 17573412 | 19726296 | Rat | n/a | region | qtl |
1000 | 71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 17593761 | 42336881 | Rat | n/a | region | qtl |
1000 | 631262 | Tcas4 | Tongue tumor susceptibility QTL 4 | 7.29 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 14 | 17622561 | 42337007 | Rat | n/a | region | qtl |
1000 | 61413 | Eae10 | Experimental allergic encephalomyelitis QTL 10 | 3.5 | | nervous system integrity trait (VT:0010566) | percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) | 14 | 17622685 | 18274498 | Rat | n/a | region | qtl |
1000 | 2313397 | Coatc1 | Coat color QTL1 | | | coat/hair pigmentation trait (VT:0010463) | coat/hair color measurement (CMO:0001808) | 14 | 18541332 | 63541332 | Rat | n/a | region | qtl |
1000 | 61420 | Pia6 | Pristane induced arthritis QTL 6 | 4.9 | | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 14 | 18631345 | 42337007 | Rat | n/a | region | qtl |
1000 | 10755459 | Coatc15 | Coat color QTL 15 | | 0.01681 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 14 | 19836944 | 64836944 | Rat | n/a | region | qtl |
1000 | 70187 | Pancm5 | Pancreatic morphology QTL 5 | 16.7 | | pancreas mass (VT:0010144) | pancreas weight to body weight ratio (CMO:0000630) | 14 | 30320092 | 80829842 | Rat | n/a | region | qtl |
1000 | 2324617 | Coatc2 | Coat color QTL 2 | | 0.001 | coat/hair pigmentation trait (VT:0010463) | pigmented coat/hair area to total coat/hair area ratio (CMO:0001810) | 14 | 30767025 | 39153750 | Rat | n/a | region | qtl |
1000 | 1300154 | Bp189 | Blood pressure QTL 189 | 3.04 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 14 | 30883777 | 68757901 | Rat | n/a | region | qtl |
1000 | 2313089 | Bss81 | Bone structure and strength QTL 81 | 3.4 | 0.0001 | body length (VT:0001256) | body length, nose to rump (CMO:0000079) | 14 | 37669719 | 82669719 | Rat | n/a | region | qtl |
1000 | 2313100 | Bss82 | Bone structure and strength QTL 82 | 3 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft cross-sectional area (CMO:0001717) | 14 | 37669719 | 82669719 | Rat | n/a | region | qtl |
1000 | 2313084 | Bss83 | Bone structure and strength QTL 83 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft endosteal cross-sectional area (CMO:0001716) | 14 | 37669719 | 82669719 | Rat | n/a | region | qtl |
1000 | 2313048 | Bss84 | Bone structure and strength QTL 84 | 3.1 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 14 | 37669719 | 82669719 | Rat | n/a | region | qtl |
1000 | 738037 | Hcas6 | Hepatocarcinoma susceptibility QTL 6 | 2.93 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 14 | 39057237 | 83368335 | Rat | n/a | region | qtl |